GlassScriptPhysician profile
Maher N Bazzi
NPI 1861920829
$33,231.30
in general payments reported to CMS, 2019-2025
10 companies · $4,448 in 2025
The $4,448 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $193 · 2021: $93.91 · 2022: $14.50 · 2023: $12K · 2024: $17K · 2025: $4,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $19K · Travel and Lodging: $8,424 · Food and Beverage: $4,883 · Education: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $19,000.00 |
| Travel and Lodging | $8,423.97 |
| Food and Beverage | $4,882.61 |
| Education | $623.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,892.39 | 2020-2025 | Ensite Precision, Ensite, Aveir |
| Medtronic, INC. | $13,139.45 | 2023-2025 | Crome Dr Mri Surescan, Amplia Mri Quad Crt-D Surescan, Selectsecure |
| Boston Scientific Corporation | $1,353.00 | 2023-2025 | Versacross Access Solution, Intellamap Orion, Farapulse |
| Astrazeneca Pharmaceuticals LP | $349.15 | 2020-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $160.20 | 2023 | Camzyos |
| Biosense Webster, INC. | $138.72 | 2025 | Carto 3, Nuvision Ice Catheter |
| Abiomed | $124.83 | 2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.16 | 2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2021 | |
| Atricure, INC. | $13.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Bazzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.